Skip to Main Content

Paper Details

Blocking the IL-1 receptor reduces cardiac transplant ischemia and reperfusion injury and mitigates CMV-accelerated chronic rejection.
Am J Transplant
7
2021
Author NameAffiliation
Suzanne S FeiOregon National Primate Research Center, Oregon Health & Science University
Lina GaoOregon National Primate Research Center, Oregon Health & Science University
Craig N KreklywichVaccine and Gene Therapy Institute, Oregon Health & Science University
Daniel N StreblowVaccine and Gene Therapy Institute, Oregon Health & Science University
Daniel N StreblowOregon Health & Science University
  • 1 - 5

Datasets